It is a hypogycaemic agent belonging to the second generation sulfonylureas . 
It appears to lower blood glucose by stimulating insulin release from beta cells in the pancreatic islets possibly due to increased intracellular cAMP


  • Non insulin dependent diabetes.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.